Clinical trial
Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in…
NCT00408850 · Baker Heart Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00408850 |
|---|---|
| Title | Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity |
| Official title | Mechanisms of Sympathetic Overactivity in the Metabolic Syndrome: Effects of Reversing Insulin Resistance by Drug Treatment |
| Lead sponsor | Baker Heart Research Institute, Other |
| Collaborators | National Heart Foundation, Australia |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Pioglitazone, sugar pill |
| Enrollment | 44 |
| Start date | Nov 1, 2008 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Dec 7, 2006 |
| Last update posted | Jan 17, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: